A Novel Panel of Rabbit Monoclonal Antibodies and Their Diverse Applications Including Inhibition of Epsilon Toxin Oligomerization.

TitleA Novel Panel of Rabbit Monoclonal Antibodies and Their Diverse Applications Including Inhibition of Epsilon Toxin Oligomerization.
Publication TypeJournal Article
Year of Publication2018
AuthorsLinden JR, Telesford K, Shetty S, Winokour P, Haigh S, Cahir-McFarland E, Antognetti G, Datta A, Wang T, Meier W, Vartanian T
JournalAntibodies (Basel)
Volume7
Issue4
Date Published2018 Oct 25
ISSN2073-4468
Abstract

The pore-forming epsilon toxin (ETX) produced by is among the most lethal bacterial toxins known. Sensitive antibody-based reagents are needed to detect toxin, distinguish mechanisms of cell death, and prevent ETX toxicity. Using B-cell immuno-panning and cloning techniques, seven ETX-specific monoclonal antibodies were generated from immunized rabbits. ETX specificity and sensitivity were evaluated via western blot, ELISA, immunocytochemistry (ICC), and flow cytometry. ETX-neutralizing function was evaluated both in vitro and in vivo. All antibodies recognized both purified ETX and epsilon protoxin via western blot with two capable of detecting the ETX-oligomer complex. Four antibodies detected ETX via ELISA and three detected ETX bound to cells via ICC or flow cytometry. Several antibodies prevented ETX-induced cell death by either preventing ETX binding or by blocking ETX oligomerization. Antibodies that blocked ETX oligomerization inhibited ETX endocytosis and cellular vacuolation. Importantly, one of the oligomerization-blocking antibodies was able to protect against ETX-induced death post-ETX exposure in vitro and in vivo. Here we describe the production of a panel of rabbit monoclonal anti-ETX antibodies and their use in various biological assays. Antibodies possessing differential specificity to ETX in particular conformations will aid in the mechanistic studies of ETX cytotoxicity, while those with ETX-neutralizing function may be useful in preventing ETX-mediated mortality.

DOI10.3390/antib7040037
Alternate JournalAntibodies (Basel)
PubMed ID31544887
PubMed Central IDPMC6698963
Grant ListR01 NS066007 / NS / NINDS NIH HHS / United States
R01 NS104350 / NS / NINDS NIH HHS / United States
na / / Biogen /

Weill Cornell Medicine Neurology 525 E. 68th St.
PO Box 117
New York, NY 10065 Phone: (212) 746-6575